The sliding scale was 3 units of Humalog
insulin for every 50 mg/dL > 150 mg/dL.
Comparison of Humalog
Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan.
Details were not disclosed for most of the studies, as the majority have not yet completed, but GSK did announce findings from one trial testing albiglutide against Lilly's insulin drug Humalog
given on top of Sanofi's Lantus.
[R] insulin has been available for some time but the recent introduction of two new Humalog
[R] insulin preparations--Humalog
mix[R] 25 and Humalog
mix[R] 50--has resulted in multiple errors in New Zealand.
The US firm's sales figures for the insulin products Humalog
, Humulin and Byetta indicated of continually high underlying growth, especially in the sales of insulin analogues, analyst Rune Majlund Dahl said.
The approval is based upon review of a 26-week, phase III, open-label, active control study of Apidra in comparison with Humalog
(both administered pre-meal) in 572 children and adolescents with Type 1 diabetes.
The pen only dispenses Humalog
, insulin made by Lilly and used at mealtimes.
Humulin and Humalog
mixes are good for ten days after first use; NPH and Novolog for 14 days; and Humalog
, Novolog, Apidra, and Lantus for 28 days.
And of course, that Humalog
is a second-tier medication (maybe I should use purified pork insulin?
The Food and Drug Administration on Monday approved Humalog
, a product that is essentially conventional insulin with a twist.
Additionally, the company loses market protection next year on Humalog
, another of its top-selling drugs.
The move also stands to enable the company to meet rising demand for its insulins--including Humalog
(insulin lispro) and Humulin (human insulin)--while upgrading to state-of-the-art technology and readying for its insulin pipeline.
Junior KwikPen insulin lispro injection 100 units/mL is now available by prescription for the treatment of diabetes in the U.
The makers of insulin lispro found it was scientifically justified to use the previous safety and effectiveness data from the approval of Humalog
to support the approval of insulin lispro injections.
In this double-blind, randomized, crossover study, 36 patients with type 1 diabetes used individualized doses of either BioChaperone Lispro or Humalog
as the short acting insulin in their multiple daily injection regimen, over two periods of 14 days.